We are monitoring the impact of COVID-19 on MEA Aptamers Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1076
Pages: 145

MEA Aptamers Market Size (2022 to 2027)

The size of the Middle East & Africa aptamers market is forecasted to be worth USD 13.72 million in 2022 and USD 16.87 million by the end of 2027, growing at a CAGR of 4.23% from 2022 to 2027.

The Aptamers market in MEA is projected to be fuelled by the increasing trend of R&D investments in pharmaceutical and biotechnology industries, technological advancements in Aptamers, and the growing prevalence of life-threatening diseases across the region. Also, the patent expiry of SELEX (systematic creation of ligands by exponential improvement technology) and the low price and great productivity of aptamers in binding to big molecules associated with antibodies are driving the market growth.

In Addition, the increasing investment and funding by the government and private organizations for the development of healthcare infrastructure and research activities are enabling new market entrants and key players to introduce their new aptamer services for different applications expected to expand the market growth. Furthermore, diseases such as cardiovascular, neurodegenerative, and acquired immunodeficiency syndrome are the major factors influencing the demand for new and effective detection assays based on aptamer therapy.  

The demand for the new diagnostic assay and increasing research activity in emerging markets such as South Africa, UAE, and Saudi Arabia uplifts regional market growth. In addition, efforts by many prominent players to create novel aptamers for research and development applications are significant drivers driving this segment's dominance. Because of its unique chemical characteristics, the Autobody technology requires less development time and provides effective Adsorption, Distribution, Metabolism, and Excretion (ADME) qualities.

However, unfavorable reimbursement policies and lack of awareness about the Aptamers are limiting the market growth. Also, incomplete regulatory policies and a lack of understanding about aptamers and technical expertise may restrain the overall MEA market growth.

This research report has been segmented and sub-segmented the Middle East & Africa Aptamers Market into the following categories:

By Type: 

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By Application: 

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User: 

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA Aptamers Market is expected to account for a moderate share in the global market during the forecast period. The increasing level of research and development activities on Aptamers, presence of key market players, regaining economic growth in the developing countries in the region are augmenting the market growth. Countries such as South Africa, UAE, and Saudi Arabia are likely to contribute to the MEA regional market growth. Research and Development, Therapeutics Development, Diagnostics, and Other Applications are some of the main applications that may be explored in the aptamers market. Due to key players' launch of innovative diagnostic kits, the "Diagnostics" category led the market in 2022 and is expected to retain its dominance by 2027.

The South African aptamers market is projected to account dominant share in the MEA Aptamers market during the forecast period. Advancements in aptamer development technologies, favorable reimbursement policies, and increasing R&D activities fuel market growth. In Addition, a rising number of companies are investing in the Aptamers market. Furthermore, the increasing prevalence of life-threatening illnesses such as cancer has prompted several firms to develop novel aptamer-based detection tests.

On the other hand, emerging countries such as UAE and Saudi Arabia are anticipated to showcase a promising share in the MEA Aptamers market in the coming future. In addition, the increasing number of companies investing in this market with the advent of new technologies in aptamers and Cost-effectiveness too plays a major role in supporting the market demand for Aptamers.

KEY MARKET PLAYERS:

Companies playing an active role in the Middle East & Africa aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Peptide Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Nucleic Acid Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Therapeutics Development Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Research and Development Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Bio-Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Academic and Rsearch centers Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  13. Middle East Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  14. Middle East Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  15. Africa Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  16. Africa Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  17. Africa Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  19. Middle East & Africa DNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East & Africa RNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  21. Middle East & Africa XNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  22. Middle East Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  23. Africa Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample